Immutep Receives A$2.7 million R&D Tax Incentive from French Government

September 23, 2022

https://www.globenewswire.com/news-release/2022/09/23/2521749/0/en/Immutep-Receives-A-2-7-million-R-D-Tax-Incentive-from-French-Government.html

SYDNEY, AUSTRALIA, Sept. 23, 2022 (GLOBE NEWSWIRE) —  Immutep Limited (ASX:IMM; NASDAQ:IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce it has received a €1,804,341 (~ A$2,693,046 ) research and development (R&D) tax incentive payment in cash from the French Government under its Crédit d’Impôt Recherche scheme (CIR).

Read more at globenewswire.com

Related news for (IMMP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.